Detailed Mechanism Funding and Narrative

Years of mechanism: 2016 2017

Details for Mechanism ID: 18406
Country/Region: Caribbean Region
Year: 2017
Main Partner: Davis Memorial Hospital and Clinic
Main Partner Program: NA
Organizational Type: FBO
Funding Agency: HHS/CDC
Total Funding: $425,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $50,000
Care: Pediatric Care and Support (PDCS) $30,000
Strategic Information (HVSI) $25,000
Testing: HIV Testing and Counseling (HVCT) $25,000
Treatment: Adult Treatment (HTXS) $225,000
Treatment: Pediatric Treatment (PDTX) $70,000
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 2,405
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Female, Negative 2018 15
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: <15, Male, Negative 2018 8
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 1,386
HTS_TST Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 924
HTS_TST Sum of Test Result disaggregates 2018 72
HTS_TST_POS By Test Result: Positive 2018 72
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 39
HTS_TST_POS Service Delivery Point by Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 33
TX_CURR Aggregated Age/Sex: <15 Female 2018 28
TX_CURR Aggregated Age/Sex: <15 Male 2018 39
TX_CURR Aggregated Age/Sex: 15+ Female 2018 977
TX_CURR Aggregated Age/Sex: 15+ Male 2018 701
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 1,745
TX_CURR Sum of Aggregated Age/Sex <15 2018 67
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 1,678
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 1,745
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 7
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 9
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 219
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 157
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 392
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 392
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,571
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 1,414
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 23
TX_PVLS Numerator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 32
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 791
TX_PVLS Numerator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 568
TX_PVLS Numerator: Indication: Routine 2018 1,414
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Female Routine 2018 25
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: <15 Male Routine 2018 34
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Female Routine 2018 881
TX_PVLS_den Denominator: Aggregate Age/Sex by Indication: 15+ Male Routine 2018 631
TX_PVLS_den Denominator: Indication: Routine 2018 1,571
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 4
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 6
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 163
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2018 117
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 290
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 322
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 5
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 6
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 181
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2018 130
Cross Cutting Budget Categories and Known Amounts Total: $195,000
Key Populations: MSM and TG $110,000
Training of health workers and community outreach workers
Implementation of core HIV prevention interventions for MSM/TG that are consistent with the current PEPFAR technical guidance
Collection and use of strategic information
Conducting epidemiologic, social science, and operational research among MSM/TG and their sex partners
Monitoring and evaluation of MSM/TG programs
Key Populations: Sex Workers $85,000
Implementation of core HIV prevention interventions for SWs consistent with PEPFAR guidance on sexual prevention
Training of health workers and community outreach workers
Collection and use of strategic information on SWs and clients
Conducting epidemiologic, social science, and operational research among SWs, their partners, and clients
Monitoring and evaluation of SW programs